{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:04:54Z","timestamp":1789812294465,"version":"4.0.1"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Abstract:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Background:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    The allergens that cause sensitivity in patch tests may vary between populations and may even change over the years depending on environmental factors.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Objectives:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    We aimed to determine the frequency of sensitizing allergens in patch tests.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    The files of 1001 patients who underwent the European Baseline Series in a reference regional hospital in Turkey were screened.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    The rate of at least one positivity was found to be 45.3%. The rate of at least one positivity was 48.5% in women and 38.7% in men, which was statistically significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.003). The top three allergens with a positive reaction were nickel sulfate (21.6%), potassium dichromate (6.6%), and cobalt chloride (6.5%), respectively. While the rate of at least one positive case was 44.8% until December 2023, this rate was 48.8% after December 2023. While at least one positivity was 37.7% in those aged 65 and over, it was 45.7% in those under 65 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.258). Potassium dichromate positivity was found to be higher in men (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.007). Nickel sulfate sensitivity was higher in women and under 40 years of age (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001, respectively). Budesonide, fragrance mix I (FMI), FMII sensitivity were observed more in men (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.003,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.032,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001, respectively). Peru balsam, FMI, and FMII positivity were more common over 40 years of age (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.003,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.003,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.008, respectively). After December 2023, potassium dichromate (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.018) and FMII (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.025) decreased, while neomycin sulfate (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.015) increased.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    Although nickel allergy has decreased with the measures taken against nickel sulfate, nickel sulfate still remains the number one allergen for positive reactions. The increase in positivity for cobalt chloride and\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    -phenylenediamine, especially neomycin sulfate, suggests that regulatory measures should be taken in this regard. The rate of at least one positivity in patch testing after December 2023 with newly added allergens has increased.\n                  <\/jats:p>","DOI":"10.1089\/derm.2024.0468","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:46:09Z","timestamp":1749530769000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of European Baseline Series Patch Test Results in Adult Patients in Adana Province, Turkey; Single Center Experience"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8147-3181","authenticated-orcid":false,"given":"Merve","family":"Erko\u00e7","sequence":"first","affiliation":[{"name":"From the, *Division of Immunology and Allergy Diseases, Adana City Training and Research Hospital, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7i\u011fdem","family":"Erhan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Adana City Training and Research Hospital, Adana, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"\u00c7evirme","sequence":"additional","affiliation":[{"name":"From the, *Division of Immunology and Allergy Diseases, Adana City Training and Research Hospital, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fczin","family":"\u00d6zden","sequence":"additional","affiliation":[{"name":"From the, *Division of Immunology and Allergy Diseases, Adana City Training and Research Hospital, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12432"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14167"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.40332"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15791"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2012.02834.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01964.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13653"},{"issue":"2","key":"e_1_3_1_9_2","first-page":"206","article-title":"European standard series patch test results in contact dermatitis patients in a tertiary care hospital","volume":"54","author":"Acer E","year":"2020","unstructured":"Acer E, , Erdogan HK, , Batan T, et al. European standard series patch test results in contact dermatitis patients in a tertiary care hospital. Sisli Etfal Hastan Tip Bul. 2020; 54(2):206\u2013210; doi: 10.14744\/SEMB.2020.02703","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200228124453"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2023.127240"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2023.0188"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.29017.jdk"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00608.x"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460104.x"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000631"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200128141900"},{"key":"e_1_3_1_18_2","unstructured":"Regulation on Registration Evaluation Authorization and Restriction of Chemicals. Available from: https:\/\/www.resmigazete.gov.tr\/eskiler\/2017\/06\/20170623m1-18.htm [Last accessed: January9 2025]."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09405.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/AJCD01000219"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2017.12.007"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2023.0140"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01427.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14618"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2023.2217244"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14435"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14642"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14653"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415623512"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000240"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03327387"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/derm.2024.0468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2024.0468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2024.0468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:16:34Z","timestamp":1789809394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/derm.2024.0468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1089\/derm.2024.0468"],"URL":"https:\/\/doi.org\/10.1089\/derm.2024.0468","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}